I agree that this site is using cookies. You can find further informations here.
X
Cattamanchi, Adithya
476  results:
OpenAccess-fulltext X
Search for persons X
?
1

3HP acceptance and completion, by study arm:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.g002.  , 2024
Link: https://doi.org/10.1371/..
 
?
2

Responses to Shared Decision-Making Questionnaire:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s016.  , 2024
Link: https://doi.org/10.1371/..
 
?
3

Self-administered therapy participant pill packs:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s004.  , 2024
Link: https://doi.org/10.1371/..
 
?
4

Time spent on 3HP-related activities:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s012.  , 2024
Link: https://doi.org/10.1371/..
 
?
5

Per-patient cost of facilitated 3HP delivery from the healt..:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.g004.  , 2024
Link: https://doi.org/10.1371/..
 
?
6

CONSORT 2010 checklist of information to include when repor..:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s017.  , 2024
Link: https://doi.org/10.1371/..
 
?
7

Subgroup analyses comparing 3HP acceptance and completion a..:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s006.  , 2024
Link: https://doi.org/10.1371/..
 
?
8

Adverse events leading to 3HP discontinuation:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s009.  , 2024
Link: https://doi.org/10.1371/..
 
?
9

99DOTS implementation metrics:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s013.  , 2024
Link: https://doi.org/10.1371/..
 
?
10

Self-administered therapy participant pill packs:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s004.  , 2024
Link: https://doi.org/10.1371/..
 
?
11

Trial profile:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.g001.  , 2024
Link: https://doi.org/10.1371/..
 
?
12

Time spent on 3HP-related activities:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s012.  , 2024
Link: https://doi.org/10.1371/..
 
?
13

Subgroup analyses of the primary trial endpoint (acceptance..:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.s005.  , 2024
Link: https://doi.org/10.1371/..
 
?
14

Per-patient cost of facilitated 3HP delivery from the healt..:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.g004.  , 2024
Link: https://doi.org/10.1371/..
 
?
15

3HP acceptance and completion, by study arm:

Fred C. Semitala ; Jillian L. Kadota ; Allan Musinguzi...
doi:10.1371/journal.pmed.1004356.g002.  , 2024
Link: https://doi.org/10.1371/..
 
1-15